MU 380 structure
|
Common Name | MU 380 | ||
---|---|---|---|---|
CAS Number | 2109805-78-7 | Molecular Weight | 430.226 | |
Density | 1.9±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C15H15BrF3N7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of MU 380A novel potent, selective CHK1 inhibitor 2 nM, >80-fold selectivity over CHK2; sensitizes a variety of tumor cell lines to hydroxyurea or gemcitabine up to 10 times; shows extended inhibitory effects in cells, and unlike SCH900776, does not undergo in vivo N-dealkylation to the significantly less selective metabolite; causes higher accumulation of DNA damage in tumor cells and subsequent enhanced cell death, and is more efficacious in the A2780 xenograft mouse model. |
Name | 6-Bromo-5-[(3R)-3-piperidinyl]-3-[1-(trifluoromethyl)-1H-pyrazol-4-yl]pyrazolo[1,5-a]pyrimidin-7-amine |
---|---|
Synonym | More Synonyms |
Description | A novel potent, selective CHK1 inhibitor 2 nM, >80-fold selectivity over CHK2; sensitizes a variety of tumor cell lines to hydroxyurea or gemcitabine up to 10 times; shows extended inhibitory effects in cells, and unlike SCH900776, does not undergo in vivo N-dealkylation to the significantly less selective metabolite; causes higher accumulation of DNA damage in tumor cells and subsequent enhanced cell death, and is more efficacious in the A2780 xenograft mouse model. |
---|---|
References | References 1. Samadder P, et al. Mol Cancer Ther. 2017 Sep;16(9):1831-1842. View Related Products by Target Checkpoint Kinase (Chk) |
Density | 1.9±0.1 g/cm3 |
---|---|
Molecular Formula | C15H15BrF3N7 |
Molecular Weight | 430.226 |
Exact Mass | 429.052429 |
LogP | 1.78 |
Index of Refraction | 1.750 |
Pyrazolo[1,5-a]pyrimidin-7-amine, 6-bromo-5-[(3R)-3-piperidinyl]-3-[1-(trifluoromethyl)-1H-pyrazol-4-yl]- |
6-Bromo-5-[(3R)-3-piperidinyl]-3-[1-(trifluoromethyl)-1H-pyrazol-4-yl]pyrazolo[1,5-a]pyrimidin-7-amine |